These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28178037)

  • 1. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
    Narang P; Ianovich F; Sarai SK; Lippmann S
    J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
    Bryson EO; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2013 Jun; 29(2):e18. PubMed ID: 23519216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine.
    Cohen MB; Stewart JT
    J ECT; 2013 Jun; 29(2):e23-4. PubMed ID: 23519222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation.
    Brydges D; Tibrewal P; Waite S; Dhillon R
    Aust N Z J Psychiatry; 2016 Apr; 50(4):386-7. PubMed ID: 26508796
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report.
    O'Brien EM; Rosenquist PB; Kimball JN; Dunn GN; Smith B; Arias LM
    J ECT; 2010 Jun; 26(2):131-3. PubMed ID: 19710618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.
    Mizrak A; Koruk S; Ganidagli S; Bulut M; Oner U
    J Anesth; 2009; 23(1):6-10. PubMed ID: 19234815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option.
    Tzabazis A; Schmitt HJ; Ihmsen H; Schmidtlein M; Zimmermann R; Wielopolski J; Münster T
    J ECT; 2013 Sep; 29(3):189-95. PubMed ID: 23792779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postictal agitation after electroconvulsive therapy.
    Tzabazis AZ; Schmitt HJ; Muenster T
    J ECT; 2014 Sep; 30(3):e27-8. PubMed ID: 24820949
    [No Abstract]   [Full Text] [Related]  

  • 10. Premedication effect of dexmedetomidine and alfentanil on seizure time, recovery duration, and hemodynamic responses in electroconvulsive therapy.
    Moshiri E; Modir H; Bagheri N; Mohammadbeigi A; Jamilian H; Eshrati B
    Ann Card Anaesth; 2016; 19(2):263-8. PubMed ID: 27052067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation.
    Cozzi G; Lega S; Giorgi R; Barbi E
    Ann Emerg Med; 2017 Jan; 69(1):125-127. PubMed ID: 27776827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postictal agitation syndrome or anxiety symptoms.
    Swartz CM
    J ECT; 2014 Sep; 30(3):e27. PubMed ID: 25144358
    [No Abstract]   [Full Text] [Related]  

  • 14. Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy: a cross-over, randomized controlled trial.
    Subsoontorn P; Lekprasert V; Waleeprakhon P; Ittasakul P; Laopuangsak A; Limpoon S
    BMC Psychiatry; 2021 Aug; 21(1):408. PubMed ID: 34404384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative sedation: An option for the management of agitation in moderate traumatic brain injury.
    Godoy DA; Tolosa K; Lubillo-Montenegro S; Murillo-Cabezas F
    Med Intensiva; 2017 Apr; 41(3):193-196. PubMed ID: 27085767
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient agitation and dexmedetomidine.
    Boyer J
    Nurse Pract; 2010 Oct; 35(10):7-11. PubMed ID: 20852392
    [No Abstract]   [Full Text] [Related]  

  • 17. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.
    Anger KE
    Curr Pharm Des; 2013; 19(22):4003-13. PubMed ID: 23228319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and Prophylactic Management of Postictal Agitation in Electroconvulsive Therapy.
    Sterina E; Gregory N; Hermida AP
    J ECT; 2023 Sep; 39(3):136-140. PubMed ID: 36215425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-electroconvulsive therapy agitation with etomidate.
    Freeman SA
    J ECT; 2009 Jun; 25(2):133-4. PubMed ID: 19494736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy.
    Guler G; Akin A; Tosun Z; Ors S; Esmaoglu A; Boyaci A
    Paediatr Anaesth; 2005 Sep; 15(9):762-6. PubMed ID: 16101707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.